PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40123P00396THIS IS a purchase ORDER for — Bracane Company

Bracane Company holds $1.5M across 11 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 14, 2026 PoP end — agencies typically plan 12–18 months ahead.

Fda Office Of Acq Grant Svcs

Awarding office

Bracane Company

Recipient

Sep 14, 2026

PoP end

$647K

Obligated

$873K

Potential

541690

NAICS

AJ11

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Bracane Company — $90

Contract facts

NONE

Contract number75F40123P00396

AgencyFda Office Of Acq Grant Svcs

Awarding officeFda Office Of Acq Grant Svcs

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentBracane Company

CAGE3B2Y7

UEIKRGPL7AL94P8

NAICS541690

PSCAJ11

Place of performanceSILVER SPRING MD

Pricing typeFirm Fixed Price

Extent competedNot Competed Under SAP

PoP startSep 11, 2023

PoP end (current)Sep 14, 2026

PoP end (w/ options)Sep 14, 2027

Obligated$647K

Current value$647K

Potential value$873K

THIS IS A PURCHASE ORDER FOR CLINICAL OPERATIONS AND CLINICAL TRIAL SITE MONITORING. is a federal NONE award for Fda Office Of Acq Grant Svcs held by Bracane Company. Estimated value $873K ($647K obligated). Current period of performance ends Sep 14, 2026 (potential Sep 14, 2027). Last award drew 1 bidder. Place of performance: SILVER SPRING MD.

THIS IS A PURCHASE ORDER FOR CLINICAL OPERATIONS AND CLINICAL TRIAL SITE MONITORING.

Recompete timing

Public

● Expiring in 7 days

Current PoP ends Sep 14, 2026 (7 days remaining). Agencies typically plan 12–18 months ahead — at 0.2 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Bracane Company — $1.5M obligated across 11 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$1.5M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75F40123P00396?

75F40123P00396 (THIS IS a purchase ORDER for) is a Fda Office Of Acq Grant Svcs award with a potential value of $873K, currently held by Bracane Company. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40123P00396?

Fda Office Of Acq Grant Svcs awarded 75F40123P00396 to Bracane Company (potential $873K).

Who is the incumbent on 75F40123P00396?

Bracane Company is the incumbent with $1.5M across 11 related awards in SCOUT’s public footprint. The current period of performance ends Sep 14, 2026.

When does Bracane Company’s 75F40123P00396 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 14, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75F40123P00396 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthlyLatest procurement action Sep 10, 2025